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Abstract
Introduction—Federal recommendations for providing quality family planning services were 
published in 2014 and included preconception care (PCC). This paper aims to describe the 
prevalence of PCC delivery among publicly funded clinics, prior to the recommendations.
Methods—Prevalence of providing occasional or frequent PCC in the last 3 months and having 
written protocols for recommended PCC screenings were estimated in 2015 using survey data 
collected from a nationally representative sample of publicly funded clinic administrators (2013–
2014, N=1,615). Analyses included examination of differential distributions of outcomes by clinic 
characteristics (p<0.05) and multivariable regression.
Results—Prevalence of occasional or frequent PCC delivery was 81% for women and 38% for 
men. The percentage of clinics with written protocols for specific PCC screenings ranged from 
74% to 88% (women) and 66% to 83% (men). Prevalence of having written protocols for all PCC 
screenings was 29% for women and 22% for men. Characteristics negatively associated with 
having written protocols for all PCC screenings for women and men (respectively) were as 
follows: not receiving Title X funding (adjusted prevalence ratio [APR]=0.6, 95% CI=0.50, 0.76; 
APR=0.6, 95% CI=0.47, 0.77) and being a community health center (APR=0.5, 95% CI=0.37, 
0.72; APR=0.5, 95% CI=0.30, 0.67); health department (APR=0.7, 95% CI=0.61, 0.87; APR=0.6, 
95% CI=0.49, 0.76); or hospital/other (APR=0.6, 95% CI=0.50, 0.79; APR=0.6, 95% CI=0.43, 
0.75) (versus Planned Parenthood).
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Conclusions—Provision of PCC appears to differ by clinic characteristics and by interpretation 
of the phrase “preconception care,” suggesting opportunities for education and improvement.
Introduction
In 2014, the Centers for Disease Control and Prevention (CDC) and the Office of Population 
Affairs published clinical recommendations, “Providing Quality Family Planning Services” 
(QFP), which identified preconception care (PCC) as a core family planning service,1 and 
bolstered earlier CDC recommendations that recognized PCC as a critical component of 
health care for women of reproductive age.2 The QFP recommendation for PCC identifies 
services that are appropriate to provide in the context of a family planning visit and therefore 
constitute a subset of all PCC services that have been recommended for women and men.1–4 
Appendix Table 1 (available online) summarizes the PCC screenings that QFP recommends 
providing during family planning visits.1
Integrating PCC into family planning visits is a novel approach for some providers, and 
extensive efforts are being made to promote adoption of the QFP recommendations among 
family planning and primary care providers. A key audience for QFP is providers working in 
clinics funded by Title X, a federal program that provides subsidized family planning 
services for nearly 5 million low-income women and men annually.5
The objective of this study was to describe the prevalence of PCC delivery and written 
protocols for PCC in the publicly funded, U.S. family planning clinic network, which 
includes community health centers (CHCs), health departments, Planned Parenthood health 
centers, outpatient hospitals, and other clinics. This study covers the time period before the 
release of the 2014 QFP recommendations, supports dissemination and implementation of 
the QFP recommendations, and provides a baseline for benchmarking uptake of the 
recommendations over time.
Methods
Data
In 2013–2014, a nationally representative sample of publicly funded U.S. clinics that 
provide family planning (N=4,000) were identified from a Guttmacher Institute database and 
surveyed. A request to complete the survey was directed to the administrator of each clinic, 
but the primary role of respondents varied and included administrators, medical directors, 
and nurse/nurse practitioner managers. Postage-paid return envelopes and surveys were 
mailed; respondents were also given the option to complete the survey online. Reminder 
postcards were sent to non-respondents, followed by second mailings and follow-up 
telephone calls. Per recommendations from the Council of American Survey Research 
Organizations (www.casro.org/), calculated response rates assume that the proportion of 
eligible respondents in the unknown subgroup is equivalent to the proportion of eligible 
respondents in the subgroup with known eligibility or ineligibility. The final Council of 
American Survey Research Organizations response rate was 49.3% (n=1,615). CDC’s IRB 
approval was not needed for this project because CDC was not engaged in human subjects 
research; the project was approved as public health practice.
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Measures
Gender-specific frequency measures of providing any PCC (undefined in the survey) to 
women (n=1,577) or men (n=1,556) were created from two gender-specific questions that 
asked, In the past 3 months, about how often did your health center provide preconception 
health care for women/men? Four response options were presented as a Likert-type scale 
that were combined for analyses: never or rarely versus occasionally or frequently.
A binary outcome (yes/no) for having a written clinical protocol to assess clients’ 
reproductive life plans (RLPs) during contraceptive counseling was created and defined as 
“asking about clients’ intentions regarding the number and timing of pregnancies in the 
context of their personal values and life goals.”
Information from a multipart question was used to examine protocols for other specific PCC 
screenings that were queried in the survey. Administrators were asked whether their clinic’s 
recommendations for specific, onsite, routine screenings for female and male clients during 
initial or follow-up family planning visits were specified in a written protocol (yes/no). Of 
note, the multipart question did not mention PCC, even though many of the specific queried 
screenings are QFP PCC services. Screening was defined as routinely asking questions 
about a client’s history or performing a physical exam or laboratory test in average-risk, 
asymptomatic people to help assess risk factors for (or the presence of) a specific disease or 
condition. For female clients, the survey asked whether or not the clinic had written 
protocols recommending the following PCC screenings: intimate partner and sexual 
violence, alcohol and drug use, BMI, tobacco use, blood pressure, diabetes, depression, 
immunizations, chlamydia, gonorrhea, syphilis, and HIV.1,2 Some recommended PCC 
assessments (Appendix Table 1, available online) were not available in the survey data (i.e., 
screenings for medical history, sexual health assessment, folic acid intake, human papilloma 
virus immunization, hepatitis B immunization, and hepatitis C virus). For male clients, the 
examined screenings were the same as for women except intimate partner and sexual 
violence.1–3 Gender-specific binary outcomes for having written protocols for all 
aforementioned PCC screenings (yes/no) were also created.
Characteristics of interest included receipt of Title X funding (yes/no); clinic type (CHC, 
health department, Planned Parenthood, hospital/other); clinical focus (reproductive health, 
primary care, other); service area (mostly urban/suburban, mostly rural, combination); and 
annual family planning caseload (<1,000, 1,000–9,999, ≥10,000). Owing to the large 
number of “other” responses for clinical focus (22%), write-in responses were reviewed and 
recoded to reflect “reproductive health” or “primary care” as appropriate. Examples of write-
in responses for “other” that were not recoded included “immunizations,” “public health,” 
and “communicable disease.”
Statistical Analysis
In 2015, the overall prevalence and SEs of three outcomes were estimated separately by 
client gender: (1) occasional or frequent provision of any PCC within the last 3 months; (2) 
having written protocols for specific recommended PCC screenings; and (3) having written 
protocols for all recommended PCC screenings that were available in the data. Pearson chi-
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square tests were used to assess differential distributions in the prevalence of outcomes by 
characteristics (p<0.05). Differential distributions of having written protocols for specific 
PCC screenings were assessed by only Title X funding status and clinic type (p<0.05). These 
same analyses were conducted for RLP assessment (not by client gender). Multivariable 
generalized linear models with Poisson distribution were used to estimate the adjusted 
prevalence ratios (APRs) and 95% CIs (controlling for all characteristics described above) 
for the following outcomes separately by client gender: occasional or frequent provision of 
any PCC in the last 3 months, having written protocols for specific PCC screenings, and 
having written protocols for all PCC screenings. All analyses were conducted using 
weighted data and Stata, version 13, to adjust for the complex survey design and non-
response.
Results
The sample included 1,615 clinics, represented by CHCs (37%); health departments (31%); 
Planned Parenthood centers (9%); and hospitals/other (23%) (Table 1). Approximately half 
were Title X–funded (49%); had a primary care focus (48%); reported mostly rural service 
area (48%); and had annual family planning caseloads <1,000 (51%). Most (81%) clinics 
reported that they occasionally (28%) or frequently (53%) provided any PCC to women in 
the previous 3 months, but fewer (38%) reported occasional (21%) or frequent (17%) PCC 
provision to men during the same time period. All examined characteristics were 
significantly associated with occasional or frequent PCC provision in unadjusted analyses 
for female clients, and all, except Title X funding status, were significantly associated with 
PCC provision for male clients. Clinics with annual family planning caseloads <1,000 had 
the lowest prevalence of any PCC delivery for women (73%) and men (31%).
Statistically significant associations between not receiving Title X funding and occasional or 
frequent PCC for women remained in the adjusted model (APR=0.9, 95% CI=0.87, 0.98). 
Similarly, the association between all clinic types and occasional or frequent PCC for female 
clients remained statistically significant in the adjusted models (Table 1). Relative to 
Planned Parenthood health centers, CHCs (APR=1.2, 95% CI=1.04, 1.30); health 
departments (APR=1.2, 95% CI=1.08, 1.30); and hospitals/other organizations (APR=1.2, 
95% CI=1.07, 1.30) were more likely to report any PCC delivery to female clients in the past 
3 months. CHCs were also more likely to report any PCC delivery to male clients in the past 
3 months (APR=1.5, 95% CI=1.12, 1.93) compared with Planned Parenthood health centers. 
Relative to clinics with annual family planning caseloads ≥5,000, those with annual family 
planning caseloads <1,000 were less likely to report any PCC delivery to female (APR=0.9, 
95% CI=0.79, 0.93) or male (APR=0.7, 95% CI=0.56, 0.84) clients in the past 3 months.
The percentage of clinics with written protocols for assessing RLPs (for all clients) was 
57%, and was higher among Title X–funded clinics (76%) versus non–Title X–funded 
clinics (35%, p<0.0001). Written protocols for RLP assessment also varied by clinic type 
(ranging from 30% for CHCs to 92% for Planned Parenthood, p<0.0001).
For other specific PCC screenings with female clients during initial or follow-up family 
planning visits, the percentage of clinics with written protocols was lowest for syphilis 
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(74%) and diabetes (76%) and highest for blood pressure (87%) and tobacco use (88%) 
(Appendix Table 2, available online). The percentage of clinics that reported having written 
protocols for female clients for specific PCC screenings was significantly higher among 
clinics with Title X funding (84%–94%) compared with those without Title X funding 
(59%–84%), with the exception of diabetes (78% vs 73%, respectively, p=0.058). However, 
after adjusting for other characteristics, statistically significant associations between not 
having Title X funding and having written protocols remained for only a subset of specific 
PCC screenings: RLP assessment (APR=0.6, 95% CI=0.57, 0.74); intimate partner and 
sexual violence (APR=0.9, 95% CI=0.83, 0.94); alcohol and drug use (APR=0.9, 95% 
CI=0.88, 0.99); chlamydia (APR=0.9, 95% CI=0.81, 0.91); gonorrhea (APR=0.9, 95% 
CI=0.81, 0.91); syphilis (APR=0.8, 95% CI=0.76, 0.89); and HIV (APR=0.9, 95% CI=0.81, 
0.91) (Figure 1). Differences in the proportion of clinics with written protocols for female 
clients for each specific PCC screening also varied significantly by clinic type, except for 
diabetes (p=0.67) (Appendix Table 2, available online). Planned Parenthood health centers 
had the highest percentages for having written protocols for each specific PCC screening for 
women (range, 80%–100%), except for immunizations (which was slightly higher among 
health departments), and CHCs had the lowest percentages (range, 54%–81%), except for 
BMI (which was lowest among hospitals/other clinic types).
The percentage of clinics with written protocols for specific PCC screenings for male clients 
during initial or follow-up family planning visits was lowest for diabetes (66%) and syphilis 
(70%) and highest for blood pressure (80%) and tobacco use (83%) (Appendix Table 2, 
available online). The percentage of clinics that reported having written protocols for male 
clients for each specific PCC screening was significantly higher among organizations with 
Title X funding compared with those without Title X funding, with a few exceptions: BMI 
(p=0.508); diabetes (p=0.292); depression (p=0.879); and immunizations (p=0.140). After 
adjusting for other characteristics, non–Title X–funded clinics were significantly less likely 
to have written protocols for all specific PCC screenings for male clients except 
immunizations (p=0.419) (Figure 2). Differences in the proportions of clinics with written 
protocols for each specific PCC screening for male clients also varied significantly by clinic 
type, except for immunizations (p=0.095). Planned Parenthood health centers had the 
highest percentages for having written protocols for each PCC screening except for diabetes 
(range, 70%–98%), which was slightly higher among CHCs. Health departments had the 
second highest percentages of having written protocols for other PCC screenings for men, 
except for BMI, blood pressure, and depression (which were higher among all other health 
center types). CHCs had the lowest percentages of having written protocols for screening 
men for alcohol/drug use (72%); chlamydia (59%); gonorrhea (58%); syphilis (52%); and 
HIV (60%).
The percentage of clinics with written protocols for all of the gender-specific PCC 
screenings was 29% for women and 22% for men (Table 2). The likelihood of having written 
protocols for all recommended PCC screenings for women was lower among clinics without 
Title X funding (versus with Title X funding) (APR=0.6, 95% CI=0.50, 0.76). Compared 
with Planned Parenthood health centers, CHCs (APR=0.5, 95% CI=0.37, 0.72); health 
departments (APR=0.7, 95% CI=0.61, 0.87); and hospitals/other clinic types (APR=0.6, 
95% CI=0.50, 0.79) were less likely to have written protocols for all PCC screenings for 
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female clients. Clinics with a focus on primary care (versus reproductive health) were less 
likely to have written protocols for all PCC screenings for women (APR=0.8, 95% CI=0.60, 
0.98). Prevalence of having written protocols for all recommended PCC screenings for men 
was lower among clinics without Title X funding (versus with Title X funding) (APR=0.6, 
95% CI=0.47, 0.77). Compared with Planned Parenthood health centers, CHCs (APR=0.5, 
95% CI=0.30, 0.67); health departments (APR=0.6, 95% CI=0.49, 0.76); and hospitals/other 
clinic types (APR=0.6, 95% CI=0.43, 0.75) were less likely to have written protocols for all 
PCC screenings for male clients.
Discussion
These findings suggest that many publicly funded clinics report that they are providing PCC 
to women and men who are receiving family planning services. Most U.S. publicly funded 
clinics (81%) reported that they occasionally or frequently provided any PCC to women, and 
38% reported that they occasionally or frequently provided PCC to men. When specific PCC 
screenings were considered, the percentage of clinics with written protocols for PCC 
screenings during family planning visits was high for both women (range, 74%–88%) and 
men (range, 66%–83%). Yet, the findings reveal that efforts are needed to promote RLP 
assessments for all family planning clients, given only 57% of surveyed clinics reported that 
they have written protocols for RLP assessment.
The findings indicate some priorities for supporting implementation of the QFP 
recommendations on PCC. Overall, the delivery of PCC services to men lags behind PCC 
services to women, in almost every context. There is substantial room for improvement for 
promoting written protocols for all recommended PCC screenings during family planning 
visits, as only 29% of surveyed clinics reported having such for female clients and even 
fewer reported having protocols for all recommended PCC screenings for male clients 
(22%). All clinic types were less likely than Planned Parenthood health centers to have 
written protocols recommending all PCC screenings for female or male clients. CHCs may 
be most in need of improving PCC, as they reported the lowest prevalence of having written 
protocols for assessing RLPs (30%) and frequently had the lowest prevalence of having 
written protocols for specific female and male PCC screenings. Additionally, having written 
protocols for all recommended PCC screenings was less likely among clinics with an 
emphasis on primary health care (versus reproductive health focus) and clinics that were not 
Title X–funded (versus those that were Title X–funded). The latter finding is consistent with 
previous reports that found enhanced service delivery was associated with Title X 
funding.6,7
Of note, several findings in this analysis suggest that there may be misunderstanding about 
the term “preconception care.” In particular, the percentage of clinics that reported 
occasional or frequent PCC to men (38%) was substantially lower than the percentages of 
clinics with written protocols recommending specific PCC screenings for men (66%–83%). 
Similarly, the percentage of Planned Parenthood health centers that reported providing any 
PCC services was substantially lower than their report of having a written protocol for 
specific recommended screenings. These inconsistencies suggest that some administrators 
may not understand the specific components of PCC and thereby under-report their actual 
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practices when asked about PCC in general. Conversely, some administrators may 
conceptualize their work as PCC but that work may not be supported by written protocols.
Provider barriers to PCC delivery include time constraints and competing priorities, 
complexity of the topic, and a lack of resources.8 Therefore, strategies for promoting 
delivery of appropriate PCC screenings include establishing written protocols, conducting 
staff training, and implementing system supports that simplify decision making (e.g., 
electronic clinic decision support systems to triage risk factors and remind providers of 
screening interval recommendations). The QFP recommendations are useful in clarifying the 
scope of PCC that should be provided as part of quality care for women and men of 
reproductive age.1
Much of the existing literature describing PCC relies on postpartum women’s recollections 
of clinical encounters that occurred more than a year prior.9–13 As the data used in this 
analysis represent a cross section of randomly selected publicly funded clinics that offer 
family planning, this report adds to the small literature that is based on providers’ report of 
reproductive services,6,7 and provides a unique snapshot of the extent to which 
administrators in the U.S. report delivering PCC to women and men seeking family planning 
services.
Limitations
Misclassification is possible owing to under-reporting or related to PCC frequency, as PCC 
was undefined. Additionally, the respondents’ familiarity with the medical operations of 
their clinics is unknown. Self-reported data always raise the possibility of desirability bias. 
For example, subjective assessments of PCC delivery frequency may be infiated. On the 
other hand, estimates of having written protocols for PCC screenings may not have been 
affected because written protocols are verifiable. The decision to combine response options 
occasionally and frequently to describe PCC delivery is debatable. Some might argue that 
there is little difference between occasionally and rarely, and suggest those should all be 
lumped together with never. However, using frequently alone to define PCC delivery did not 
materially impact results. Selection bias is also possible. The response rate was suboptimal 
(49%), although perhaps higher than most healthcare provider surveys.14 To limit potential 
non-response bias, weights were used in all analyses to increase accuracy of estimates. 
Additionally, the data about specific PCC screening services do not describe actual delivery 
of services—rather, just the presence of a written protocol recommending routine provision 
of those services. Having written protocols does not guarantee implementation or service 
delivery. Finally, the data do not address the quality of the written protocols.
Conclusions
This report illuminated the fact that many clinics are likely already providing PCC for 
women and men. Moreover, it highlighted clinics’ characteristics where PCC delivery could 
be improved, and may serve as a baseline for evaluating alignment of medical practices for 
providing PCC services with implementation of recommended quality family planning 
services.1 Ongoing surveillance of medical provider PCC practices is needed to monitor 
progress on implementation of QFP. Additional research is needed to improve understanding 
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of possible barriers to delivery of PCC that may explain the differential PCC practices that 
were reported by clinic characteristics. Finally, well-designed epidemiologic studies are 
needed to build the evidence of the impact of specific PCC services on improved health 
outcomes for women, men, and infants.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix. Supplementary data
Supplementary data associated with this article can be found at http://dx.doi.org/10.1016/
j.amepre.2016.02.013.
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Figure 1. 
Association between no Title X funding and written protocols for preconception care 
screenings for women.
RLP, reproductive life plan
aMultivariable general linear models with Poisson distribution used to estimate the adjusted 
prevalence ratios controlling for type of health center, health center focus, service area, and 
family planning caseload. The reference group was health centers that received Title X 
funding.
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Figure 2. 
Association between no Title X funding and written protocols for preconception care 
screenings for men.
RLP, reproductive life plan.
aMultivariable general linear models with Poisson distribution used to estimate the adjusted 
prevalence ratios controlling for type of health center, health center focus, service area, and 
family planning caseload. The reference group was health centers that received Title X 
funding.
Robbins et al. Page 11
Am J Prev Med. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Robbins et al. Page 12
Ta
bl
e 
1
Sa
m
pl
e 
Ch
ar
ac
te
ris
tic
s a
nd
 D
el
iv
er
y 
of
 A
ny
 P
re
co
nc
ep
tio
n 
Ca
re
 to
 F
em
al
e 
an
d 
M
al
e 
Cl
ie
nt
sa
C
lin
ic
 ch
ar
ac
te
ri
st
ic
s
Sa
m
pl
e (
n
=
1,
61
5) 
%
Fe
m
a
le
 c
lie
nt
s (
n
=
1,
57
7) 
%
 (S
E)
A
PR
b  
(95
%
 C
I)
M
al
e 
cl
ie
nt
s (
n
=
1,
55
6) 
%
 (S
E)
A
PR
b  
(95
%
 C
I)
O
ve
ra
ll
80
.8
 (0
.01
)
—
37
.8
 (0
.01
)
—
R
ec
ei
pt
 o
f T
itl
e 
X
 fu
nd
in
g
 
Ye
s
49
.3
84
.6
 (0
.01
)
re
f
36
.3
 (0
.01
)
re
f
 
N
o
50
.7
77
.2
 (0
.02
)
0.
9 
(0.
87
, 0
.98
)
39
.2
 (0
.02
)
0.
9 
(0.
76
, 1
.02
)
 
χ2
 
p-
v
al
ue
<
0.
00
1
0.
21
3
Ty
pe
 o
f h
ea
lth
 c
en
te
r
 
CH
C
36
.6
77
.1
 (0
.02
)
1.
2 
(1.
04
, 1
.30
)
43
.1
 (0
.02
)
1.
5 
(1.
12
, 1
.93
)
 
H
ea
lth
 d
ep
ar
tm
en
t
31
.4
84
.7
 (0
.01
)
1.
2 
(1.
08
, 1
.30
)
31
.3
 (0
.02
)
1.
0 
(0.
82
, 1
.29
)
 
Pl
an
ne
d 
pa
re
nt
ho
od
9.
1
77
.1
 (0
.03
)
re
f
36
.5
 (0
.03
)
re
f
 
H
os
pi
ta
l/o
th
er
c
23
.0
82
.8
 (0
.02
)
1.
2 
(1.
07
, 1
.30
)
39
.0
 (0
.03
)
1.
3 
(0.
99
, 1
.59
)
 
χ2
 
p-
v
al
ue
0.
00
3
<
0.
00
1
Cl
in
ic
al
 fo
cu
s
 
R
ep
ro
du
ct
iv
e 
he
al
th
40
.0
83
.9
 (0
.01
)
re
f
35
.7
 (0
.02
)
re
f
 
Pr
im
ar
y 
ca
re
48
.4
77
.0
 (0
.02
)
1.
0 
(0.
89
, 1
.02
)
40
.7
 (0
.02
)
1.
1 
(0.
88
, 1
.28
)
 
O
th
er
11
.6
86
.3
 (0
.02
)
1.
1 
(1.
00
, 1
.13
)
33
.2
 (0
.03
)
1.
1 
(0.
85
, 1
.30
)
 
χ2
 
p-
v
al
ue
<
0.
00
1
0.
03
9
Se
rv
ic
e 
ar
ea
 
M
os
tly
 u
rb
an
/su
bu
rb
an
30
.7
84
.0
 (0
.02
)
1.
0 
(0.
99
, 1
.11
)
44
.4
 (0
.02
)
1.
2 
(1.
03
, 1
.41
)
 
M
os
tly
 ru
ra
l
48
.3
77
.4
 (0
.01
)
re
f
31
.9
 (0
.02
)
re
f
 
Co
m
bi
na
tio
n 
(ur
ba
n/s
ub
u
rb
an
 a
nd
 ru
ra
l)
21
.0
84
.7
 (0
.02
)
1.
1 
(1.
00
, 1
.13
)
40
.7
 (0
.03
)
1.
1 
(0.
96
, 1
.35
)
 
χ2
 
p-
v
al
ue
0.
00
2
<
0.
00
1
A
nn
ua
l f
am
ily
 p
la
nn
in
g 
ca
se
lo
ad
 
<
1,
00
0
50
.6
72
.8
 (0
.02
)
0.
9 
(0.
79
, 0
.93
)
30
.5
 (0
.02
)
0.
7 
(0.
56
, 0
.84
)
 
1,
00
0–
4,
99
9
36
.3
89
.4
 (0
.01
)
1.
0 
(0.
98
, 1
.11
)
43
.6
 (0
.02
)
1.
0 
(0.
80
, 1
.14
)
 
≥5
,0
00
13
.2
83
.5
 (0
.02
)
re
f
46
.0
 (0
.03
)
re
f
 
χ2
 
p-
v
al
ue
<
0.
00
1
<
0.
00
1
Am J Prev Med. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Robbins et al. Page 13
a N
at
io
na
l s
ur
ve
y 
da
ta
 o
f p
ub
lic
ly
 fu
nd
ed
 h
ea
lth
 c
en
te
rs
 th
at
 o
ffe
r f
am
ily
 p
la
nn
in
g 
se
rv
ic
es
. P
re
co
nc
ep
tio
n 
ca
re
 w
as
 d
ef
in
ed
 a
s s
el
f-r
ep
or
te
d 
oc
ca
sio
na
l o
r f
re
qu
en
t p
ro
v
isi
on
 o
f p
re
co
nc
ep
tio
n 
he
al
th
 c
ar
e 
in
 
th
e 
pr
ev
io
us
 3
 m
on
th
s.
b M
ul
tiv
ar
ia
bl
e 
ge
ne
ra
l l
in
ea
r m
od
el
s w
ith
 P
oi
ss
on
 d
ist
rib
u
tio
n 
us
ed
 to
 e
sti
m
at
e 
th
e 
A
PR
s c
on
tro
lli
ng
 fo
r a
ll 
va
ria
bl
es
 in
 ta
bl
e.
 B
ol
df
ac
e 
in
di
ca
te
s s
ta
tis
tic
al
 si
gn
i3
ca
nc
e 
(p<
0.
05
).
c I
nc
lu
de
s p
riv
at
e 
no
n-
pr
of
it 
or
ga
n
iz
at
io
ns
, a
nd
 o
th
er
.
A
PR
, a
dju
ste
d p
rev
al
en
ce
 ra
tio
; C
H
C,
 c
om
m
un
ity
 h
ea
lth
 c
en
te
r.
Am J Prev Med. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Robbins et al. Page 14
Table 2
Associations Between Clinic Characteristics and Having Written Protocols for All Recommended 
Preconception Care Screeningsa
Female clientsb Male clientsc
Clinic characteristics % (SE) APRd (95% CI) % (SE) APRd (95% CI)
Overall 29.1 (0.01) — 22.3 (0.01) —
Receipt of Title X funding
 Yes 41.2 (0.01) ref 30.5 (0.01) ref
 No 17.1 (0.01) 0.6 (0.50, 0.76) 14.1 (0.01) 0.6 (0.47, 0.77)
 χ2 p-value <0.001 <0.001
Type of health center
 CHC 15.1 (0.02) 0.5 (0.37, 0.72) 13.0 (0.02) 0.5 (0.30, 0.67)
 Health department 40.5 (0.02) 0.7 (0.61, 0.87) 28.1 (0.01) 0.6 (0.49, 0.76)
 Planned parenthood 55.1 (0.03) ref 44.6 (0.03) ref
 Hospital/othere 24.8 (0.02) 0.6 (0.50, 0.79) 19.7 (0.02) 0.6 (0.43, 0.75)
 χ2 p-value <0.001 <0.001
Clinical focus
 Reproductive health 41.3 (0.02) ref 29.9 (0.01) ref
 Primary care 17.0 (0.01) 0.8 (0.60, 0.98) 14.7 (0.01) 1.0 (0.73, 1.27)
 Other 36.8 (0.03) 1.2 (0.96, 1.39) 27.5 (0.03) 1.2 (0.98, 1.57)
 χ2 p-value <0.001 <0.001
Service area
 Mostly urban/suburban 28.1 (0.02) 1.0 (0.81, 1.19) 21.9 (0.02) 0.9 (0.75, 1.19)
 Mostly rural 28.9 (0.01) ref 22.2 (0.01) ref
 Combination (urban/suburban and rural) 31.4 (0.02) 1.0 (0.87, 1.24) 23.4 (0.02) 1.0 (0.78, 1.23)
 χ2 p-value 0.511 0.844
Annual family planning caseload
 <1,000 25.4 (0.01) 0.9 (0.70, 1.12) 19.6 (0.01) 0.8 (0.63, 1.13)
 1,000–4,999 34.8 (0.02) 1.1 (0.90, 1.36) 25.8 (0.02) 1.0 (0.79, 1.31)
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Female clientsb Male clientsc
Clinic characteristics % (SE) APRd (95% CI) % (SE) APRd (95% CI)
 ≥5,000 30.0 (0.01) ref 27.8 (0.03) ref
 χ2 p-value <0.001 0.002
aNational survey data of publicly funded health centers that provide family planning services (n=1,511) based on recommendations by Providing 
Quality Family Planning Services.2
b
Defined as routinely asking questions about a client’s history or performing a physical exam or laboratory test in average-risk asymptomatic 
female clients to help assess reproductive life plan, history of intimate partner and sexual violence, alcohol and drug abuse, BMI, tobacco use, 
blood pressure, diabetes, depression, immunizations, chlamydia, gonorrhea, syphilis, and HIV.
c
Defined as routinely asking questions about a client’s history or performing a physical exam or laboratory test in average-risk asymptomatic male 
clients to help assess reproductive life plan, history of alcohol or drug abuse, BMI, tobacco use, blood pressure, diabetes, depression, 
immunizations, chlamydia, gonorrhea, syphilis, and HIV.
d
Multivariable general linear models with Poisson distribution used to estimate the APR controlling for all clinic characteristics shown in table; 
Boldface indicates statistical significance (p<0.05).
e
Includes private non-profit organizations, and other.
APR, adjusted prevalence ratio; CHC, community health center.
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